Company intelligence

BioStem Technologies

Biotech

Recent changes

  1. Oct 2, 2026BioStem Technologies Files S-1 With The SEC Pulse story
  2. Sep 29, 2026Raised $3M SEC EDGAR Form D

Funding History

1 event ยท sources dated per row
DateEventAmountValuationInvestorsSource
Sep 29, 2026funding round$3Mโ€”
SEC EDGAR Form D

Latest Pulse

  1. BioStem Technologies Files S-1 With The SECPompano Beach-based BioStem Technologies, a Nasdaq-listed regenerative-medicine company (ticker BSEM), filed an S-1 with the SEC on October 2 -- a registration statement from an already-listed company, not an IPO or an exchange uplisting.โ†’
  2. VSee Health Files S-1 For $5M Equity LineAlready-public VSee Health filed an S-1 on October 1 to register the resale of up to 3.54 million shares by ClearThink Capital Partners under a $5 million equity purchase agreement -- a financing registration, not an IPO.โ†’
  3. This Week's IPO Filings Are Microcaps And SPACsPulse checks this week's SEC S-1 pipeline against the archive's own mega-deal IPOs: of roughly a dozen new filings, most are small-cap and SPAC vehicles, not the next Anthropic or SpaceX.โ†’

Coverage Timeline

newest first
  1. Oct 2, 2026IPOBioStem Technologies Files S-1 With The SECโ†’

All Coverage

Related Companies

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data ยท Suggest a correction